Cellomatics is thrilled to announce that we have been shortlisted for the BioUK Awards 2026 in the Most Impactful CRO of the Year category.
The BioUK Awards (formerly the OBN Awards) is a well-established and highly regarded awards programme for the life sciences industry, designed to celebrate innovation and outstanding achievement across the sector. Now in its 18th year, the awards feature 12 categories and recognise companies at all stages of development, as well as inspirational leadership, exciting innovation and the delivery of of real-life, tangible results that are destined to have a positive impact on patients.
Cellomatics is delighted to be recognised as one of three companies named as finalists for the Most Impactful CRO of the Year category. This shortlisting is a testament to the hard work and dedication of the entire Cellomatics team and the services and strategic impact they deliver as a company.
The awards will take place on Wednesday 21 October at Royal Lancaster London, we look forward to attending and networking with our industry peers at the event.
Take a look at our achievements page to see the other awards Cellomatics has won and been shortlisted for.
